Patient Portal Technologies, Inc. (PPRG)
Baldwinsville, NY, US
Patient Portal Technologies, Inc., located in Baldwinsville, New York, specializes in developing and delivering solutions designed to enhance patient relationship management. These offerings cater to healthcare facilities, patients and their families, and medical personnel alike. Among its key offerings is HEALTHCAST, a diverse television network that delivers customized informational and educational content directly to patients, visitors, and staff. The company also provides MEDEX PRESCRIPTION DELIVERY, a complimentary service for medication delivery, and PHONE & TV RENTAL, an interactive communication hub that integrates billing and collection capabilities. Further enhancing patient experience, TELCIERGE INSTANT RESPONSE empowers patients to address non-medical requirements through a single phone call. QUICK PULSE SURVEYS enable facilities to gather valuable feedback for operational improvements, while MEDCLIPS offer condition-specific video content, accessible for either in-facility or remote viewing, both before and after a hospital stay.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | -99.75% | -99.99% | -100.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%-10.3% Q2'10: -37.6% (vs Q2'09)
-
EPS growth Medical - Care Facilities: +19.2%-66.7% Q2'10: +85.7% (vs Q2'09)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%-35.0% Q2'10: -4.9% (vs Q2'09)
-
EBIT margin Medical - Care Facilities: +11.3%-18.6% Q2'10: -0.5% (vs Q2'09)
-
ROIC Medical - Care Facilities: +6.8%-24.7% Q2'10: -0.4% (vs Q2'09)
-
Share dilution Medical - Care Facilities: +0.0%+16.9% Q2'10: +10.8% (vs Q2'09)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×-3.02× Q2'10: 2.44× (vs Q2'09)
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2009-10-05 | LEIGHTON DOUGLAS | Director | — | I | Sries C Preferred Stock, 7,500 shares | 0 | 0.00 | — | 0 | — | ↗ |
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Thomas Hagan | Chief Financial Officer, Principal Accounting Officer, Secretary & Director | 2.0K | male |
| Brian Kelly | Chief Executive Officer | — | male |
| John O'Mara | President | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PPRG
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
